An actionable insight signifying the pathophysiological state of an individual in Biomarker & CDx – MarketsandMarkets

1 Like comments off
Biomarker and Companion Diagnostics

Biomarker and Companion Diagnostics

MarketsandMarkets bring to you the 8th Annual Biomarker and CDx Conference scheduled to be held on 8th – 9th February 2023 in San Diego, USA.

SAN DIEGO, CALIFORNIA, UNITED STATES, January 12, 2023 /EINPresswire.com/ — The pandemic increased the growth and development of companion diagnostics and drove investments into the biomarker industry. As a result of the development of targeted medicines, the healthcare ecosystem has changed, increasing the demand for companion diagnostics.

It is important to consider the clinical and financial advantages later when selecting which biomarker tests to pursue for future study and development. Early health economic modelling gives decision-makers tools to evaluate the potential consequences of biomarker innovation. New and complex technologies are improving biomarker discovery and development, raising the possibility that additional clinical uses of biomarkers may be employed to enhance illness diagnosis, prognosis, and monitoring. However, there is always room for advancement in terms of clinical biomarker discovery automation and validation.
We at MARKETSANDMARKETS continuously work to supply our biomarker researchers, physicians, and laboratory staff with cutting-edge technology for precise research operations through our international conferences globally. The 8th ANNUAL BIOMARKER & COMPANION DIAGNOSTICS CONFERENCE will be held at Double Tree by Hilton, San Diego – Mission Valley on February 8th and 9th, 2023. We are dedicated to organising educational conferences that foster intra- and cross-speciality networking to expand the potential of the global healthcare ecosystem.

The Expert Panel will take you through their presentations which will include problems, solutions and services in the Clinical Applications of Biomarkers in Immuno-Oncology, Neurology, and Inflammatory Diseases. Attendees would evidence the examples and the case studies which will help in creating the revenue. The keynote presentations would also help the attendees understand the issues related to the clinical translation of biomarkers.

BOOK YOUR SEATS NOW!

We are looking forward to having you back in our midst as you all collaborate to expand the boundaries of medicine and therapy!

COME & SIGN UP FOR THE CONFERENCE TODAY!

Nayantara Patil
MarketsandMarkets
+91 7030560809
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn
Instagram
Other

Rate this post

You might like

About the Author: EINPresswire